首页> 美国卫生研究院文献>In Vivo >Undervaluation of Radiotherapy for Gross Desmoid Tumors: The Need for Absolute Volume Assessment
【2h】

Undervaluation of Radiotherapy for Gross Desmoid Tumors: The Need for Absolute Volume Assessment

机译:毛细血管肿瘤的放射治疗的低估:绝对批量评估的需求

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background/Aim: To compare absolute volume (AV) assessment according to Response Evaluation Criteria in Solid Tumors (RECIST) for the response evaluation of desmoid tumors (DTs) treated with radiotherapy.  Patients and Methods: Eighteen patients with DTs ≥3 cm in size were included. Results: The median follow-up duration was 78.0 months. Five patients achieved a complete response according to RECIST, seven reached a partial response (PR), and one eventually exhibited progression. The overall response rate was 61%, the median time to PR was 8.0 months. Six patients achieved stable disease, although three developed progressions. Of the six patients with a PR, the median change in maximum diameter was −46%, and the median change in maximum volume was −84%. Three patients could have been diagnosed with progression at least 6 months earlier if the AV increment was considered. Conclusion: An AV assessment is essential for an accurate response assessment of DTs and radiotherapy seems feasible as a first-line treatment for DTs.
机译:背景/宗旨:根据响应评估标准进行比较固体肿瘤(RECIST)的响应评估标准,用于放射治疗的DESMOID肿瘤(DTS)的响应评估。患者及方法:包括18例DTS≥3厘米的患者。结果:中位后续时间为78.0个月。根据再循环,五名患者实现了完整的反应,七个达到了部分反应(PR),最终表现出了进展。总体反应率为61%,中位数至3例为8.0个月。八名患者达到稳定的疾病,尽管三次发展进展。在PR的六名患者中,最大直径的中值变化为-46%,最大体积的中值变化为-84%。如果考虑过AV递增,则需要至少6个月诊断为进展的诊断。结论:AV评估对于DTS的准确响应评估至关重要,并且放疗似乎可行作为DTS的一线治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号